Evidence map›Paper›PMID 32931742›Full record

ArticleCancer cell2020

Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer.

Lajos Pusztai, Reneé Taylor, Sarah S Mougalian

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Lajos PusztaiYale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520-8032, USA. Electronic address: lajos.pusztai@yale.edu.
Reneé TaylorYale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520-8032, USA.
Sarah S MougalianYale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520-8032, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many breast cancer patients do not complete long-term hormonal therapies. Text messaging emerged as a tool to enhance medication compliance, but a trial of twice-weekly text message reminders (published in the Journal of Clinical Oncology) failed to improve adherence. The results, however, pave the way for 2nd generation texting approaches.

Indexed as

Breast NeoplasmsText MessagingAromatase InhibitorsCombined Modality TherapyFemaleHumansMedication AdherenceAromatase Inhibitors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.